T2 Biosystms Price Prediction
| TTOODelisted Stock | USD 0.18 0.05 21.74% |
Momentum 28
Sell Stretched
Oversold | Overbought |
Using T2 Biosystms hype-based prediction, you can estimate the value of T2 Biosystms from the perspective of T2 Biosystms response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in T2 Biosystms to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying TTOO because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
T2 Biosystms after-hype prediction price | USD 0.18 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
TTOO |
T2 Biosystms After-Hype Price Prediction Density Analysis
As far as predicting the price of T2 Biosystms at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in T2 Biosystms or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of T2 Biosystms, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
T2 Biosystms Estimiated After-Hype Price Volatility
In the context of predicting T2 Biosystms' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on T2 Biosystms' historical news coverage. T2 Biosystms' after-hype downside and upside margins for the prediction period are 0.01 and 21.72, respectively. We have considered T2 Biosystms' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
T2 Biosystms is out of control at this time. Analysis and calculation of next after-hype price of T2 Biosystms is based on 3 months time horizon.
T2 Biosystms Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as T2 Biosystms is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading T2 Biosystms backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with T2 Biosystms, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 21.54 | 0.00 | 0.17 | 0 Events / Month | 6 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.18 | 0.18 | 0.00 |
|
T2 Biosystms Hype Timeline
T2 Biosystms is at this time traded for 0.18. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.17. TTOO is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at -0.14%. %. The volatility of related hype on T2 Biosystms is about 1746.85%, with the expected price after the next announcement by competition of 0.01. About 74.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.03. T2 Biosystms had not issued any dividends in recent years. The entity had 1:100 split on the 13th of October 2023. Given the investment horizon of 90 days the next estimated press release will be within a week. Check out T2 Biosystms Basic Forecasting Models to cross-verify your projections.T2 Biosystms Related Hype Analysis
Having access to credible news sources related to T2 Biosystms' direct competition is more important than ever and may enhance your ability to predict T2 Biosystms' future price movements. Getting to know how T2 Biosystms' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how T2 Biosystms may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BIOC | Biocept | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GENE | Invictus MD Strategies | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HTGM | HTG Molecular Diagnostics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| INBS | Intelligent Bio Solutions | (0.09) | 9 per month | 4.60 | 0.13 | 11.39 | (7.32) | 40.17 | |
| IDXG | Interpace Biosciences | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BIAF | bioAffinity Technologies, | 0.13 | 4 per month | 0.00 | (0.11) | 11.27 | (7.41) | 32.01 | |
| SQL | SeqLL Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TMO | Thermo Fisher Scientific | (8.57) | 7 per month | 1.30 | 0.05 | 1.86 | (2.30) | 10.03 | |
| ILMN | Illumina | 1.09 | 9 per month | 0.00 | (0.19) | 3.88 | (5.47) | 15.07 | |
| DHR | Danaher | (0.91) | 6 per month | 0.00 | (0.07) | 2.05 | (2.24) | 12.24 | |
| WAT | Waters | (6.43) | 8 per month | 1.54 | 0.05 | 3.00 | (2.56) | 10.90 | |
| IDXX | IDEXX Laboratories | (1.35) | 9 per month | 1.46 | 0.08 | 2.72 | (2.63) | 14.45 | |
| ISPC | iSpecimen | 0.10 | 7 per month | 0.00 | (0.10) | 7.95 | (12.34) | 44.04 |
T2 Biosystms Additional Predictive Modules
Most predictive techniques to examine TTOO price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TTOO using various technical indicators. When you analyze TTOO charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About T2 Biosystms Predictive Indicators
The successful prediction of T2 Biosystms stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as T2 Biosystms, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of T2 Biosystms based on analysis of T2 Biosystms hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to T2 Biosystms's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to T2 Biosystms's related companies.
Story Coverage note for T2 Biosystms
The number of cover stories for T2 Biosystms depends on current market conditions and T2 Biosystms' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that T2 Biosystms is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about T2 Biosystms' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
T2 Biosystms Short Properties
T2 Biosystms' future price predictability will typically decrease when T2 Biosystms' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of T2 Biosystms often depends not only on the future outlook of the potential T2 Biosystms' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. T2 Biosystms' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.6 M | |
| Cash And Short Term Investments | 15.7 M |
Check out T2 Biosystms Basic Forecasting Models to cross-verify your projections. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in TTOO Pink Sheet
If you are still planning to invest in T2 Biosystms check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystms' history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |